Health
Chronicle Pharmabiz
IPC to conduct workshops for public drug testing labs
IN the backdrop of growing concerns around contaminated cough syrups in the supply chain, the Indian Pharmacopoeia Commission (IPC) will be conducting hands on training for public drug testing labs in 10 states in November in its first phase of training programmes, according to official sources.
1 min |
October 30, 2025
Chronicle Pharmabiz
India needs a PQCA mechanism to fortify drug regulation
NDIA needs a national Pharma Quality Certification & Audit (PQCA) mechanism under Quality Council of India (QCI) to fortify drug regulation, according to B Thirunavukkarasu, president, Bangalore District Chemists and Druggists Association (BDCDA).
2 min |
October 30, 2025
Chronicle Pharmabiz
Lifesciences industry steps up research to combat superbugs
LIFESCIENCES industry is working to judiciously research on an aggressive antibiotic pipeline as global AMR surveillance report underlines escalating threat for India. So long, the strides made in antibiotic discovery is slow as companies pursued for lucrative chronic disease drugs, leaving the pipeline for novel and effective antimicrobials arid. Latest findings indicate resistance to last-resort antibiotics is rising, which means existing treatments are failing.
1 min |
October 30, 2025
Chronicle Pharmabiz
IPC to launch programmes to strengthen safe use of blood
In a significant move to ensure the highest standards of quality and safety of blood and blood components used in transfusion services, the Indian Pharmacopoeia Commission (IPC) is set to conduct a series of sensitisation programmes and webinars aimed at educating and guiding officials from blood centres across the country.
1 min |
October 30, 2025
Chronicle Pharmabiz
Lifesciences industry steps up research to combat superbugs
LIFESCIENCES industry is working to judiciously research on an aggressive antibiotic pipeline as global AMR surveillance report underlines escalating threat for India. So long, the strides made in antibiotic discovery is slow as companies pursued for lucrative chronic disease drugs, leaving the pipeline for novel and effective antimicrobials arid. Latest findings indicate resistance to last-resort antibiotics is rising, which means existing treatments are failing.
1 min |
October 30, 2025
Chronicle Pharmabiz
Ayurvedic medicines offer safe paediatric alternatives: Expert
IN the wake of the tragic deaths of several children in Madhya pradesh linked to contaminated allopathic cough syrups, Prof Anand Chaudhary, former head of the Department of Rasa Shastra and Bhaishajya Kalpana at the Institute of Medical Sciences, Banaras Hindu University (BHU) in Varanasi, has strongly asserted the safety of traditional treatments.
1 min |
October 23, 2025
Chronicle Pharmabiz
RDCA issues warning to chemists on compliance with Pharmacy Act
IN a significant move for reinforcing public health and professional standards, the Delhi Pharmacy Council (DPC) has issued a strict notice mandating that the dispensing of all medicines must be carried out only by a Registered Pharmacist.
2 min |
October 23, 2025
Chronicle Pharmabiz
HC asks cos to file chart with details of banned FDCs
THE Division Bench of the Delhi High Court (HC) has asked the pharmaceutical companies to file a chart of the details related to the ban on fixed dose combinations (FDCs) and the petitions they have filed before the Court in connection with this in a certain timeframe, in order to proceed with the matter.
2 min |
October 23, 2025
Chronicle Pharmabiz
AICDF demands action against some cos in WB for illegal brand promotion
THE All India Chemists and Distributors Federation (AICDF), led by president Kailash Gupta in Delhi and general secretary Joydeep Sarkar in Kolkata, has launched a scathing complaint against several pharmaceutical marketing companies, alleging illegal brand promotion, price manipulation, and a severe 'unholy nexus' with regulatory officials.
2 min |
October 23, 2025
Chronicle Pharmabiz
Syngene International invests in peptide lab
SYNGENE International, a global contract research, development, and manufacturing organization (CRDMO), announced site upgrades to accelerate drug discovery and development, helping clients bring novel therapies to market faster at Hyderabad.
1 min |
October 23, 2025
Chronicle Pharmabiz
PCI asks institutions to complete onboarding AEBAS by December
THE Pharmacy Council of India (PCI) has informed the pharmacy institutions that those who do not fully complete the registration and onboarding process of Aadhaar Enabled Biometric Attendance System (AEBAS) will not be eligible for the approval process for the upcoming academic session 2026-27.
2 min |
October 23, 2025
Chronicle Pharmabiz
Centre to mandate QR Code on vaccines, cancer drugs, etc
THE Union Ministry of Health and Family Welfare has proposed an amendment to the Drugs Rules, 1945, to mandate labels of all vaccines, antimicrobials, narcotic and psychotropic drugs listed under the Narcotic and Psychotropic Drugs Act (NPDA), 1985, and all anticancer drugs carry QR code.
1 min |
October 23, 2025
Chronicle Pharmabiz
Clean labels mandatory in dietary supplement to prove transparency
INDIA's nutraceutical and dietary supplement industry is expanding. However, this rapid growth has also exposed gaps in regulation and oversight.
2 min |
October 23, 2025
Chronicle Pharmabiz
Dispute divides TNCDA leadership
THE ongoing tension within The Tamil Nadu Chemists and Druggists Association (TNCDA) recently escalated into an open exchange of letters, highlighting a fundamental disagreement over governance and procedural authority.
2 min |
October 23, 2025
Chronicle Pharmabiz
Over to the NMC
RECENTLY, the Karnataka State Doctors' Handwriting Improvement Association (KSDHIA) has asked the pharmacists across the state to stop accepting handwritten medical prescriptions, stating that illegible handwritten prescriptions are in direct violation of the National Medical Commission (NMC)'s Professional Conduct Regulations, and it poses serious risks to patient safety and undermines ethical medical practices.
2 min |
October 23, 2025
Chronicle Pharmabiz
PCI restores admission status to 89 institutions in Maharashtra
THE Pharmacy Council of India (PCI) has restored its earlier order denying permission to 89 pharmacy institutions, including 71 D. Pharm institutions and 18 B. Pharm institutions, in the State of Maharashtra to of fer admission to the relevant courses for the first year, for the academic year 202526, following an order from the High Court of Bombay.
1 min |
October 23, 2025
Chronicle Pharmabiz
DoP seeks Eol for manufacturing, supplying products for Brazil
THE Department of Pharma- ceuticals (DoP) has sought Expression of Interest (EoI) for manufacturing and supplying pharmaceutical prod- ucts for Brazil as a part of official engagements initiated by Brazil with India on enhancing strategic India-Brazil cooperation in the pharmaceutical and healthcare sectors.
1 min |
October 23, 2025
Chronicle Pharmabiz
India's inclusion to WHO's GCTF to benefit clinical research
THE pharma and biotech industries in the country are of the view that India’s inclusion into WHO's Global Clinical Trials Forum (GCTF), through key members like the Indian Council of Medical Research (ICMR), St. John’s Medical College, Bengaluru and Christian Medical College (CMC) Vellore, will bring in several strategic benefits for the country's clinical research landscape.
2 min |
October 23, 2025
Chronicle Pharmabiz
'Leadless pacemakers are redefining standard towards heart care'
LEADLESS pacemakers are redefining the standard of care for bradycardia, leading the way to improved heart care, said Dr. Girish Navasundi, senior consultant, interventional cardiology, Apollo Hospital, Bengaluru.
1 min |
October 23, 2025
Chronicle Pharmabiz
Everbright announces $7 mn seed investment
EVERBRIGHT Health, a techenabled managed services platform that helps mental health providers deliver advanced interventions as part of everyday care, announced a $7 million seed investment from W Health Ventures and Sanos Capital.
1 min |
October 23, 2025
Chronicle Pharmabiz
'Actions of few non-compliant entities should not tarnish reputation of entire industry'
THE actions of a few noncompliant pharma companies such as the one allegedly linked to the recent cough syrup deaths of several children in Madhya Pradesh and Rajasthan must not be allowed to tarnish the reputation of the entire industry, said Dr Premnath Shenoy, former director QA RA and patient safety, AstraZeneca and immediate past president, Indian Pharmaceutical Association, Karnataka state branch.
2 min |
October 23, 2025
Chronicle Pharmabiz
Hikal opens high potency API lab in Pune
HIKAL Ltd, the preferred long-term partner for leading global life sciences companies, has announced the inauguration of its state-of-the-art high-potency active pharmaceutical ingredient (HPAPI) Laboratory at its Integrated Innovation Centre in Pune.
1 min |
October 23, 2025
Chronicle Pharmabiz
Govt to amend MDR 2017 to add qualifications for recruitments
THE Union ministry of health and family welfare is planning an amendment to the Medical Device Rules (MDR), 2017, to incorporate the qualifications required for the recruitment of inspectors and government analysts for the medical devices vertical.
2 min |
October 23, 2025
Chronicle Pharmabiz
Pharmexcil seeks inputs from exporters to review RODTEP scheme
THE Pharmaceuticals Export Promotion Council of India (Pharmexcil) has sought inputs and comments from member pharma exporters for review of Remission of Duties and Taxes on Exported Products (RODTEP) scheme and Rebate of State and Central Taxes and Levies (RoSCTL) rates framed by the RoDTEP Committee 2025.
2 min |
October 23, 2025
Chronicle Pharmabiz
Centre to amend Rules to licensing of stem cell, gene therapy products
THe Union ministry of health and family welfare has issued a draft amendment of Drugs Rules, 1945 to enable industry to apply for manufacturing license of stem cell derived products, gene therapeutic products, among others.
2 min |
October 23, 2025
Chronicle Pharmabiz
PharmaTech Expo, LabTech Expo 2025 at Bengaluru
THE 21st edition of PharmaTech Expo & LabTech Expo, concurrent with Contract Manufacturing and Raw & Packaging Material Expo, is scheduled to take place from December 19 to 21, 2025, at the Bengaluru International Exhibition Centre (BIEC), Bengaluru.
1 min |
October 23, 2025
Chronicle Pharmabiz
'Govt should mandate PG cos to supply small quantities 'as required' to halt contamination'
THE recent public health scare linked to the contaminated Cold Erif cough syrup, which came from a manufacturing unit in Tamil Nadu, has shone a harsh light on a critical safety problem in India's drug supply chain.
1 min |
October 23, 2025
Chronicle Pharmabiz
Haryana FDA extends toxic impurity alert to ayurvedic drug makers
THE Food and Drug Administration (FDA) in Haryana has escalated its statewide crackdown on adulterated pharmaceutical raw materials, with State Drugs Controller Lalit Kumar Goel directing a 'Most Urgent' vigil that now extends to the manufacturers of ayurvedic medicines.
1 min |
October 23, 2025
Chronicle Pharmabiz
Govt drug test labs in M'rashtra well equipped to test DEG
THE Maharashtra Food and Drugs Administration (FDA) has informed that the state FDA drug testing labs are fully equipped with advanced equipment like Gas Chromatography with Mass Spectrometry (GC-MS) to test toxic chemicals like diethylene glycol (DEG) in contaminated cough syrups.
1 min |
October 23, 2025
Chronicle Pharmabiz
DoP rolls out programmes on revised PRIP scheme
THE Department of Pharmaceuticals (DOP) has initiated a series of sensitisation programmes to guide the pharma and medtech industry for smooth and seamless application on the revised Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme amended recently.
2 min |